Vident Investment Advisory, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2020$707,000
-51.2%
288,763
-5.9%
0.05%
-48.9%
Q4 2019$1,448,000
+24.9%
306,786
+13.3%
0.09%
-10.9%
Q3 2019$1,159,000
-28.6%
270,870
-2.8%
0.10%
-22.9%
Q2 2019$1,624,000
-7.8%
278,609
-49.4%
0.13%
+89.9%
Q3 2018$1,762,000
-0.7%
550,559
-6.2%
0.07%
-1.4%
Q2 2018$1,774,000
+1.7%
587,255
+46.8%
0.07%
-1.4%
Q1 2018$1,744,000
+43.8%
400,060
+36.5%
0.07%
+29.1%
Q4 2017$1,213,000
-6.4%
293,082
+38.8%
0.06%
-21.4%
Q3 2017$1,296,000
+1.7%
211,142
+3.1%
0.07%
-33.3%
Q2 2017$1,274,000
+45.6%
204,744
+48.4%
0.10%
+20.7%
Q1 2017$875,000
+42.3%
137,976
+20.0%
0.09%
+16.0%
Q4 2016$615,000
+0.5%
114,980
+5.8%
0.08%
-7.4%
Q3 2016$612,000
-0.6%
108,720
-3.1%
0.08%
-6.9%
Q2 2016$616,000
-44.2%
112,156
-24.6%
0.09%
+27.9%
Q1 2016$1,104,000
+71.2%
148,806
+91.7%
0.07%
-17.1%
Q4 2015$645,00077,6050.08%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2017
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders